2009
DOI: 10.1016/j.fertnstert.2008.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
58
0
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(68 citation statements)
references
References 29 publications
(20 reference statements)
8
58
0
2
Order By: Relevance
“…It has previously been reported that the gene expression and circulating levels of visfatin were increased in women with PCOS compared with age-and BMImatched controls (Tan et al 2006a, Chan et al 2007, Kowalska et al 2007, Panidis et al 2008, Carmina et al 2009, Ozkaya et al 2010, Plati et al 2010, Seow et al 2011, as shown in Table 1. However, several recently published studies did not find a difference in plasma or serum visfatin levels between patients with PCOS and control groups (Guducu et al 2012, Lajunen et al 2012, Olszanecka-Glinianowicz et al 2012.…”
Section: Visfatinmentioning
confidence: 86%
See 1 more Smart Citation
“…It has previously been reported that the gene expression and circulating levels of visfatin were increased in women with PCOS compared with age-and BMImatched controls (Tan et al 2006a, Chan et al 2007, Kowalska et al 2007, Panidis et al 2008, Carmina et al 2009, Ozkaya et al 2010, Plati et al 2010, Seow et al 2011, as shown in Table 1. However, several recently published studies did not find a difference in plasma or serum visfatin levels between patients with PCOS and control groups (Guducu et al 2012, Lajunen et al 2012, Olszanecka-Glinianowicz et al 2012.…”
Section: Visfatinmentioning
confidence: 86%
“…Most studies, however, did not find any significant differences in serum leptin levels in women with PCOS when compared with age-and weight-matched controls (Table 1; Chapman et al 1997, Laughlin et al 1997, Mantzoros et al 1997, Micic et al 1997, Rouru et al 1997, Gennarelli et al 1998, Carmina et al 2009. No significant difference was found in circulating leptin levels between the ovulatory and anovulatory PCOS patients either (Carmina et al 2009). Furthermore, a very recent study showed that there was no effect of PCOS on either adipose leptin expression or plasma leptin levels (Svendsen et al 2012).…”
Section: Leptinmentioning
confidence: 93%
“…serum TNF and IL-6) (Diamanti-Kandarakis et al, 2007b;Guzelmeric et al, 2007;Atamer et al, 2008). They also present clinical features of premature atherosclerosis such as impaired pulse wave velocity (PWV), increased carotid intima media wall thickness (IMT), presence of carotid plaque, and increased coronary artery calcification (Carmina et al, 2008;. Therefore, it is now recognised that treating IR in PCOS patients will effectively treat the symptoms and may also prevent the long-term sequelae of this endocrinopathy (De Leo et al, 2003).…”
Section: Pcos and Obesitymentioning
confidence: 99%
“…In fact, obesity, predominantly abdominal, is recognized as an important determinant of metabolic risk in these patients (Azziz et al, 2004;Spritzer and Wiltgen, 2007). In PCOS, elevated leptin serum levels have been associated with amount of adipose tissue, waist circumference, insulin resistance, and hyperandrogenemia (Spritzer et al, 2001;Carmina et al, 1999Carmina et al, , 2005, while adiponectin levels have been reported to be decreased (Ardawi and Rouzi, 2005;EscobarMorreale, 2006;Jakubowska et al, 2008;Carmina et al, 2005Carmina et al, , 2009 or unchanged (Orio et al, 2003;Sprangler et al, 2004;Gulcelik et al, 2006). In this paper, we briefly review the emerging evidence linking adipose tissue expression of leptin and adiponectin and serum adipokine levels in women with PCOS.…”
Section: Introductionmentioning
confidence: 97%